Abbott Laboratories Stock News

The investigational transcatheter aortic valve implantation (TAVI) system will complement Abbott's Navitor™ TAVI system for aortic stenosis, a common and life-threatening heart valve disease The investigational system is designed to offer best-in-class heart blood flow, ease of use and precision Approximately 9% of older Americans have aortic stenosis1 ABBOTT PARK, Ill., Nov. 25, 2024 /PRNewswi...

Abbott has a very stable gross profit margin, while the company's revenue and return on invested capital could be more consistent. The company has increased their dividend for more than 50 years and should announce their 53rd dividend increase in December. Considering ABT is trading for a slight premium and has a long-term expected rate of return of 8%, potential investors will need to be patient.

2 Dividend Kings to Buy for a Lifetime of Passive Income

NEW YORK--(BUSINESS WIRE)--MACH Alliance, a not-for-profit industry body dedicated to advocating for open, best-of-breed technology ecosystems, today announced the expansion of its thriving education program, rideMACH, which has nearly tripled its enrollment in half a year. The eLearning program is introducing a new expansion course and upcoming credentials, and it is broadening support by appo...

These are income stocks you can buy and hold forever.

You'll also like these stocks for their track record of earnings growth.

Drugmaker Abbott India reported a rise in second-quarter profit on Thursday, helped by strong demand for its gastrointestinal and anti-infective medications.

Shares of Abbott Laboratories (ABT) are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a jury cleared the two infant formula makers of liability for a boy's debilitating intestinal disease.